Advertisement

Topics

Lilly Corporate Center Company Profile

08:58 EST 12th December 2018 | BioPortfolio

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME’s principal focus has been on applying its proprietary AMEsystem™ technology platform to the full range of <!--LGfEGNT2Lhm-->protein therapeutic candidates including antibodies, cytokines, hormones and enzymes to develop novel human biotherapeutic candidates.
Since February 2004, AME has been a wholly-owned subsidiary of <!--LGfEGNT2Lhm-->Eli Lilly and Company and is an integral part of Lilly’s research organization. Lilly, a leading innovation-driven corporation is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs.

While geographically separate, AME works closely with Lilly colleagues in Indianapolis and around the world, sharing a corporate legacy of integrity and commitment to quality that spans more than a century.

 

Lilly(TM) is a registered trademark of Eli Lilly and Company.  BioPortfolio's use of the Lilly(TM) trademark on this site does not imply any affiliation with or endorsement by Eli Lilly and Company.  If you are looking for Eli Lilly and Company's official website, please visit www.lilly.com.

Location

Mail Drop Code 1854
Indianapolis
Indiana
46285
United States of America

Contact

Phone: 317-276-2790
Fax: 317-276-4878


News Articles [1328 Associated News Articles listed on BioPortfolio]

Lilly Diabetes Center of Excellence Established

Eli Lilly and the Indiana Bioscience Research Institute (IBRI) have partnered with Indiana University (IU) School of Medicine to create the Lilly Diabetes Center of Excellence (LDCE), with the goal of...

Eli Lilly and Company: Eli Lilly and Company Files 10-Q

Eli Lilly and Company Eli Lilly and Company: Eli Lilly and Company Files 10-Q 06-Nov-2018 / 16:58 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is s...

Eli Lilly and Company: Eli Lilly and Company Files 8-K

Eli Lilly and Company Eli Lilly and Company: Eli Lilly and Company Files 8-K 16-Oct-2018 / 20:00 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is so...

Eli Lilly and Company: Eli Lilly and Company Files Form 8-K

Eli Lilly and Company Eli Lilly and Company: Eli Lilly and Company Files Form 8-K 06-Nov-2018 / 14:54 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer ...

Eli Lilly and Company: ELI LILLY AND COMPANY FILES FORM 3 AND FORM 4

Eli Lilly and Company Eli Lilly and Company: ELI LILLY AND COMPANY FILES FORM 3 AND FORM 4 29-Oct-2018 / 18:34 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. Th...

Eli Lilly and Company: Eli Lilly and Company: Lilly Declares Fourth-Quarter 2018 Dividend

Eli Lilly and Company Eli Lilly and Company: Eli Lilly and Company: Lilly Declares Fourth-Quarter 2018 Dividend 15-Oct-2018 / 20:02 CET/CEST Dissemination of a French Regulatory News, transmit...

Eli Lilly: The Issues With Drug Development and Regaining the Public's Trust

In this episode of PharmaTelevision News Review, Paul Larsmon talks with Gino Santini, Vice President, Corporate Strategy, at Eli Lilly. Filmed at BIO-Europe 2009, they discuss: • Eli Lilly's CEO's ...

Eli Lilly closes $1.6bn ARMO BioSciences acquisition

Eli Lilly has completed the acquisition of immuno-oncology company ARMO BioSciences in an all-cash deal valued at nearly $1.6bn. Lilly...Read More... The post Eli Lilly closes $1.6bn ARMO BioSciences ...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Indiana Oxygen Company, Inc.]

Xigris [Eli Lilly and Company]

These highlights do not include all the information needed to use XIGRIS safely and effectively. See full prescribing information for XIGRIS.XIGRIS (drotrecogin alfa (activated)) injection, powder, ly...

Axid ar [Wyeth Consumer Healthcare]

Axid AR (nizatidine)

Humulin [Eli Lilly and Company]

HUMULIN 70/3070% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (rDNA ORIGIN)100 UNITS PER ML (U-100)

Gemzar [Eli Lilly and Company ]

These highlights do not include all the information needed to use GEMZAR safely and effectively. See full prescribing information for GEMZAR.GEMZAR (gemcitabine for injection) Powder, Lyophilized, For...

PubMed Articles [550 Associated PubMed Articles listed on BioPortfolio]

Comparative study of quality of life of elderly nursing home residents and those attneding a day Center.

The aim of this study was to compare the QOL of the elderly living in nursing homes and those who attend the Day Center (Centro Dia) at the the Asilo Vila Vicentina in the city of Bauru/SP. The sample...

A novel allele for inducible Cre expression in germinal center B cells.

The germinal center reaction is essential for efficient humoral immunity, but it can also give rise to B cell lymphomas. Cre/loxP-mediated conditional gene knock-out or knock-in can be used for the ge...

Calorimetric Dark Matter Detection with Galactic Center Gas Clouds.

We demonstrate that dark matter heating of gas clouds, hundreds of parsecs from the Milky Way Galactic Center, provides a powerful new test of dark matter interactions. To illustrate, we set a new bo...

Head and Neck Cancer in World Trade Center Responders: A Case Series.

To report on cases of head and neck cancer (HNC) among World Trade Center (WTC) responders participating in the WTC Health Program and seen at Rutgers WTC Center of Clinical Excellence.

Real-time Imaging Revealed Exoelectrogens from Wastewater Are Selected at the Center of Gradient Electric Field.

Exoelectrogens acclimated from the environment are the key of energy recovery from waste in bioelectrochemical systems. However, it is still unknown how these bacteria were selectively enriched on the...

Clinical Trials [1771 Associated Clinical Trials listed on BioPortfolio]

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

This is a non-inferiority, multi-center, randomized, controlled, single-blind, two-way crossover efficacy and safety study in subjects with Type 1 diabetes mellitus. The study involves two...

Safety and Efficacy of G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

This is a blinded, randomized crossover study to compare the safety and efficacy of G-Pen™ (glucagon injection) to Lilly Glucagon (glucagon for injection [rDNA origin]) for hypoglycemia ...

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

This study aims to assess the effects of early basal insulin therapy in previously non-diabetic de novo kidney transplant patients in reducing the incidence of new onset diabetes in partic...

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the ATU.

Lilly's Emotional and Physical Symptoms of Depression

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Companies [1540 Associated Companies listed on BioPortfolio]

Eli Lilly and Company

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that...

Lilly USA

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and fro...

Lilly Corporate Center

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. ...

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

Applied Molecular Evolution

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME...

More Information about "Lilly Corporate Center" on BioPortfolio

We have published hundreds of Lilly Corporate Center news stories on BioPortfolio along with dozens of Lilly Corporate Center Clinical Trials and PubMed Articles about Lilly Corporate Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lilly Corporate Center Companies in our database. You can also find out about relevant Lilly Corporate Center Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record